181 related articles for article (PubMed ID: 25206370)
1. The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity.
Wang X; Yang Y; Jia M; Ma C; Wang M; Che L; Yang Y; Wu J
Neural Regen Res; 2013 Jan; 8(1):39-48. PubMed ID: 25206370
[TBL] [Abstract][Full Text] [Related]
2. [Cloning and expression of fusion gene of amyloid beta binding alcohol dehydrogenase decoy peptide aptamer (TRX1-ABAD-DP-TRX2)].
Wang X; Wu J; Yang Y; Wang MY; Che LH; Yang Y
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(1):50-4. PubMed ID: 22490659
[TBL] [Abstract][Full Text] [Related]
3. rAAV/ABAD-DP-6His attenuates oxidative stress-induced injury of PC12 cells.
Jia M; Wang M; Yang Y; Chen Y; Liu D; Wang X; Song L; Wu J; Yang Y
Neural Regen Res; 2014 Mar; 9(5):481-8. PubMed ID: 25206842
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.
Yang X; Yang Y; Wu J; Zhu J
J Mol Neurosci; 2007; 33(2):180-8. PubMed ID: 17917077
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde.
Murakami Y; Ohsawa I; Kasahara T; Ohta S
Neurobiol Aging; 2009 Feb; 30(2):325-9. PubMed ID: 17707551
[TBL] [Abstract][Full Text] [Related]
8. Role of thioredoxin 1 and thioredoxin 2 on proliferation of human adipose tissue-derived mesenchymal stem cells.
Song JS; Cho HH; Lee BJ; Bae YC; Jung JS
Stem Cells Dev; 2011 Sep; 20(9):1529-37. PubMed ID: 21158569
[TBL] [Abstract][Full Text] [Related]
9. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
Zakaria A; Hamdi N; Abdel-Kader RM
Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
[TBL] [Abstract][Full Text] [Related]
10. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
Yan SD; Stern DM
Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
[TBL] [Abstract][Full Text] [Related]
12. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
13. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
[TBL] [Abstract][Full Text] [Related]
15. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
Benek O; Musílek K; Kuca K
Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
18. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial β-amyloid in Alzheimer's disease.
Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
Chen JX; Yan SD
Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]